China Approval For Akeso’s Bispecific But ASCO Data Unnerve Investors

 
• By Dexter Jie Yan
  
China pharma US trial
Akeso's ivonescimab faces twisty road to efficacy superiority over rivals • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia